EMEA-002812-PIP01-20
Key facts
| Active substance |
Rimegepant
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0285/2020
|
| PIP number |
EMEA-002812-PIP01-20
|
| Pharmaceutical form(s) |
Orodispersable Tablets
|
| Condition(s) / indication(s) |
Prevention of migraine headaches
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Pfizer Europe MA EEIG
E-mail: pip_enquiries@pfizer.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|